Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]-FAPI-74 PET/MRI in Refractory Dermatomyositis
NCT06568783Phase 2Not yet recruiting
- Start
- Dec 2024
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]-FAPI-74 in dermatomyositis (DM). Planned start Dec 2024; status: not yet recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
dermatomyositis (DM)
Beyond the preview
Go deeper on NCT06568783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06568783.